Tonix Pharma (TNXP)

Tonix Pharma Financial Statements

Tonix Pharma Financial Overview

Tonix Pharma's market cap is currently ―. The company's EPS TTM is $-7.608; its P/E ratio is -0.21; Tonix Pharma is scheduled to report earnings on August 15, 2022, and the estimated EPS forecast is $-1.45. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -26.44M$ -29.48M$ -18.54M$ -23.56M$ -20.74M
EBITDA$ -26.37M$ -29.45M$ -18.52M$ -23.55M$ -20.73M
Net Income Common Stockholders$ -26.42M$ -29.55M$ -18.53M$ -23.55M$ -20.65M
Balance Sheet
Cash Cash Equivalents And Short Term Investments$ 55.66M$ 77.07M$ 140.44M$ 164.21M$ 165.72M
Total Assets$ 223.72M$ 240.90M$ 214.77M$ 189.16M$ 183.52M
Total Debt$ 791.00K$ 864.00K$ 994.00K$ 1.07M$ 1.13M
Net Debt$ -54.87M$ -76.20M$ -139.44M$ -163.15M$ -164.59M
Total Liabilities$ 15.76M$ 22.18M$ 12.56M$ 8.67M$ 6.61M
Stockholders Equity$ 62.57M$ 87.65M$ 176.92M$ 180.49M$ 202.22M
Cash Flow
Free Cash Flow$ -51.26M$ -48.07M$ -20.70M$ -20.54M$ -21.56M
Operating Cash Flow$ -31.05M$ -22.45M$ -12.95M$ -19.11M$ -21.06M
Investing Cash Flow$ -20.22M$ -25.62M$ -7.75M$ -1.43M$ -505.00K
Financing Cash Flow$ 13.06M$ 43.77M$ 37.96M$ 22.05M$ 108.71M
Currency in USD

Tonix Pharma Earnings and Revenue History

Tonix Pharma Debt to Assets

Tonix Pharma Cash Flow

Tonix Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis